|
|
|
市場調查報告書
金磚5國各國(巴西、俄羅斯、印度、中國、南非)的遺傳基因檢驗市場:到2017年為止的展望
Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
| 出版商 |
GlobalData |
| 出版日期 |
2012年01月 |
商品編碼 |
228217 |
| 內容資訊 |
英文 Pages: 112 |
| 價格 |
|
|
金磚5國各國(巴西、俄羅斯、印度、中國、南非)的遺傳基因檢驗市場:到2017年為止的展望 是由出版商GlobalData在2012年01月所出版的。
這份英文市場調查報告書包含Pages: 112 價格從美金2500起跳。
本報告提供金磚5國各國(巴西、俄羅斯、印度、中國、南非)的遺傳基因檢驗相關市場分析，提供五國整體銷售收益·市場佔有率，及各國內的市場收益(整體市場及各部門)·企業佔有率等相關調查，以及主要企業簡介和市場佔有率等資訊彙整，為您概述為以下內容。
第1章 目錄
第2章 簡介
第3章 金磚5國各國的遺傳基因檢驗市場
- 收益總額(2003∼2017年)
- 企業佔有率(2009∼2010年)
第4章 巴西的遺傳基因檢驗市場
- 收益總額(2003∼2017年)
- 先天性的遺傳基因/染色體變異
- 其他遺傳基因檢驗
- 後天性的遺傳基因/染色體變異
- 流通佔有率(2009∼2010年)
- 企業佔有率(2009∼2010年)
第5章 俄羅斯的遺傳基因檢驗市場
- 收益總額(2003∼2017年)
- 先天性的遺傳基因/染色體變異
- 其他遺傳基因檢驗
- 後天性的遺傳基因/染色體變異
- 流通佔有率(2009∼2010年)
- 企業佔有率(2009∼2010年)
第6章 印度的遺傳基因檢驗市場
- 收益總額(2003∼2017年)
- 先天性的遺傳基因/染色體變異
- 其他遺傳基因檢驗
- 後天性的遺傳基因/染色體變異
- 流通佔有率(2009∼2010年)
- 企業佔有率(2009∼2010年)
第7章 中國的遺傳基因檢驗市場
- 收益總額(2003∼2017年)
- 先天性的遺傳基因/染色體變異
- 其他遺傳基因檢驗
- 後天性的遺傳基因/染色體變異
- 流通佔有率(2009∼2010年)
- 企業佔有率(2009∼2010年)
第8章 南非的遺傳基因檢驗市場
- 收益總額(2003∼2017年)
- 先天性的遺傳基因/染色體變異
- 其他遺傳基因檢驗
- 後天性的遺傳基因/染色體變異
- 流通佔有率(2009∼2010年)
- 企業佔有率(2009∼2010年)
第9章 金磚5國各國的遺傳基因檢驗市場主要企業
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Siemens Healthcare
- Qiagen N.V.
- Bio-Rad Laboratories, Inc.
- Gen-Probe Incorporated
第10章 附錄
圖表一覽
Abstract
Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Summary
GlobalData's new report, "Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017" provides key market data on the Genetic Testing market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within three market categories - Inborn Gene or Chromosome Alterations, Other Genetic Tests and Acquired Gene or Chromosome Alterations. The report also provides company shares and distribution shares data for the overall Genetic Testing market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older-a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that shortly after 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.
Scope
- Market size data for Genetic Testing market categories - Inborn Gene or Chromosome Alterations, Other Genetic Tests and Acquired Gene or Chromosome Alterations.
- Annualized market revenues ($m) data for each of the segments and sub-segments within the three market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.
- 2010 company shares and distribution shares data for the overall Genetic Testing market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Genetic Testing market in BRICS.
- Key players covered include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthcare, Qiagen N.V., Bio-Rad Laboratories, Inc. and Gen-Probe Incorporated.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Genetic Testing competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
TOC
1 Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What is This Report About?
3 Genetic Testing in BRICS
- 3.1 Genetic Testing, BRICS, Overall Revenue ($m), 2003-2017
- 3.2 Genetic Testing, BRICS, Company share (2009-2010)
4 Genetic Testing In Brazil
- 4.1 Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 19
- 4.2 Inborn Gene or Chromosome Alterations In Brazil
- 4.2.1 Inborn Gene or Chromosome Alterations, Brazil, Overall Revenue (2003-2017)
- 4.3 Other Genetic Tests In Brazil
- 4.3.1 Other Genetic Tests, Brazil, Overall Revenue (2003-2017)
- 4.4 Acquired Gene or Chromosome Alterations In Brazil
- 4.4.1 Acquired Gene or Chromosome Alterations, Brazil, Overall Revenue (2003-2017)
- 4.5 Genetic Testing, Brazil, Distribution Share (2009-2010)
- 4.6 Genetic Testing, Brazil, Company Share (2009-2010)
5 Genetic Testing In Russian Federation
- 5.1 Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017
- 5.2 Inborn Gene or Chromosome Alterations in Russian Federation
- 5.2.1 Inborn Gene or Chromosome Alterations, Russian Federation, Overall Revenue (2003-2017)
- 5.3 Other Genetic Tests In Russian Federation
- 5.3.1 Other Genetic Tests, Russian Federation, Overall Revenue (2003-2017)
- 5.4 Acquired Gene or Chromosome Alterations In Russian Federation
- 5.4.1 Acquired Gene or Chromosome Alterations, Russian Federation, Overall Revenue (2003-2017)
- 5.5 Genetic Testing, Russian Federation, Distribution Share (2009-2010)
- 5.6 Genetic Testing, Russian Federation, Company Share (2009-2010)
6 Genetic Testing In India
- 6.1 Genetic Testing, India, Overall Revenue ($m), USD Actual, 2003-2017
- 6.2 Inborn Gene or Chromosome Alterations in India
- 6.2.1 Inborn Gene or Chromosome Alterations, India, Overall Revenue (2003-2017)
- 6.3 Other Genetic Tests In India
- 6.3.1 Other Genetic Tests, India, Overall Revenue (2003-2017)
- 6.4 Acquired Gene or Chromosome Alterations In India
- 6.4.1 Acquired Gene or Chromosome Alterations, India, Overall Revenue (2003-2017)
- 6.5 Genetic Testing, India, Distribution Share (2009-2010)
- 6.6 Genetic Testing, India, Company Share (2009-2010)
7 Genetic Testing In China
- 7.1 Genetic Testing, China, Overall Revenue ($m), USD Actual, 2003-2017
- 7.2 Inborn Gene or Chromosome Alterations In China
- 7.2.1 Inborn Gene or Chromosome Alterations, China, Overall Revenue (2003-2017)
- 7.3 Other Genetic Tests In China
- 7.3.1 Other Genetic Tests, China, Overall Revenue (2003-2017)
- 7.4 Acquired Gene or Chromosome Alterations In China
- 7.4.1 Acquired Gene or Chromosome Alterations, China, Overall Revenue (2003-2017)
- 7.5 Genetic Testing, China, Distribution Share (2009-2010)
- 7.6 Genetic Testing, China, Company Share (2009-2010)
8 Genetic Testing In South Africa
- 8.1 Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, 2003-2017
- 8.2 Inborn Gene or Chromosome Alterations In South Africa
- 8.2.1 Inborn Gene or Chromosome Alterations, South Africa, Overall Revenue (2003-2017)
- 8.3 Other Genetic Tests In South Africa
- 8.3.1 Other Genetic Tests, South Africa, Overall Revenue (2003-2017)
- 8.4 Acquired Gene or Chromosome Alterations In South Africa
- 8.4.1 Acquired Gene or Chromosome Alterations, South Africa, Overall Revenue (2003-2017)
- 8.5 Genetic Testing, South Africa, Distribution Share (2009-2010)
- 8.6 Genetic Testing, South Africa, Company Share (2009-2010)
9 Overview of Key Companies in BRICS Genetic Testing Market
- 9.1 F. Hoffmann-La Roche Ltd.
- 9.1.1 Company Overview
- 9.1.2 Share in the BRICS Genetic Testing Market
- 9.2 Abbott Laboratories
- 9.2.1 Company Overview
- 9.2.2 Share in the BRICS Genetic Testing Market
- 9.3 Siemens Healthcare
- 9.3.1 Company Overview
- 9.3.2 Share in the BRICS Genetic Testing Market
- 9.4 Qiagen N.V.
- 9.4.1 Company Overview
- 9.4.2 Share in the BRICS Genetic Testing Market
- 9.5 Bio-Rad Laboratories, Inc.
- 9.5.1 Company Overview
- 9.5.2 Share in the BRICS Genetic Testing Market
- 9.6 Gen-Probe Incorporated
- 9.6.1 Company Overview
- 9.6.2 Share in the BRICS Genetic Testing Market
10 Appendix
- 10.1 Definitions of Markets Covered in the Report
- 10.2 Research Methodology
- 10.3 Secondary Research
- 10.4 Primary Research
- 10.5 Models
- 10.6 Forecasts
- 10.7 Expert Panels
- 10.8 GlobalData Consulting
- 10.9 Currency Conversion
- 10.10 Contact Us
- 10.11 Disclaimer
List of Tables
1.1 List of Tables
- Table 1: Genetic Testing, BRICS, Overall Revenue ($m), 2003-2017
- Table 2: Genetic Testing, BRICS, Overall Revenue ($m), Historic, 2003-2010
- Table 3: Genetic Testing, BRICS, Overall Revenue ($m), Forecast, 2010-2017
- Table 4: Genetic Testing, BRICS, Company share by Revenue ($m), USD Actual, 2009-2010
- Table 5: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, 2003-2017
- Table 6: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010
- Table 7: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
- Table 8: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010
- Table 9: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017
- Table 10: Other Genetic Tests, Brazil, Revenue ($m), Historic, 2003-2010
- Table 11: Other Genetic Tests, Brazil, Revenue ($m), Forecast, 2010-2017
- Table 12: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010
- Table 13: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017
- Table 14: Genetic Testing, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010
- Table 15: Genetic Testing, Brazil, Company share by Revenue ($m), USD Actual, 2009-2010
- Table 16: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017
- Table 17: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010
- Table 18: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
- Table 19: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010
- Table 20: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017
- Table 21: Other Genetic Tests, Russian Federation, Revenue ($m), Historic, 2003-2010
- Table 22: Other Genetic Tests, Russian Federation, Revenue ($m), Forecast, 2010-2017
- Table 23: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010
- Table 24: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017
- Table 25: Genetic Testing, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010
- Table 26: Genetic Testing, Russian Federation, Company share by Revenue ($m), USD Actual, 2009-2010
- Table 27: Genetic Testing, India, Overall Revenue ($m), USD Actual, 2003-2017
- Table 28: Genetic Testing, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010
- Table 29: Genetic Testing, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
- Table 30: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010
- Table 31: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017
- Table 32: Other Genetic Tests, India, Revenue ($m), Historic, 2003-2010
- Table 33: Other Genetic Tests, India, Revenue ($m), Forecast, 2010-2017
- Table 34: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010
- Table 35: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017
- Table 36: Genetic Testing, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010
- Table 37: Genetic Testing, India, Company share by Revenue ($m), USD Actual, 2009-2010
- Table 38: Genetic Testing, China, Overall Revenue ($m), USD Actual, 2003-2017
- Table 39: Genetic Testing, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010
- Table 40: Genetic Testing, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
- Table 41: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010
- Table 42: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017
- Table 43: Other Genetic Tests, China, Revenue ($m), Historic, 2003-2010
- Table 44: Other Genetic Tests, China, Revenue ($m), Forecast, 2010-2017
- Table 45: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010
- Table 46: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017
- Table 47: Genetic Testing, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010
- Table 48: Genetic Testing, China, Company share by Revenue ($m), USD Actual, 2009-2010
- Table 49: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, 2003-2017
- Table 50: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010
- Table 51: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
- Table 52: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010
- Table 53: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017
- Table 54: Other Genetic Tests, South Africa, Revenue ($m), Historic, 2003-2010
- Table 55: Other Genetic Tests, South Africa, Revenue ($m), Forecast, 2010-2017
- Table 56: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010
- Table 57: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017
- Table 58: Genetic Testing, South Africa, Distribution Share by Revenue ($m), USD Actual, 2009-2010
- Table 59: Genetic Testing, South Africa, Company share by Revenue ($m), USD Actual, 2009-2010
- Table 60: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Genetic Testing Market, 2010
- Table 61: Abbott Laboratories, Revenue ($m), BRICS Genetic Testing Market, 2010
- Table 62: Siemens Healthcare, Revenue ($m), BRICS Genetic Testing Market, 2010
- Table 63: Qiagen N.V., Revenue ($m), BRICS Genetic Testing Market, 2010
- Table 64: Bio-Rad Laboratories, Inc., Revenue ($m), BRICS Genetic Testing Market, 2010
- Table 65: Gen-Probe Incorporated, Revenue ($m), BRICS Genetic Testing Market, 2010
- Table 66: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010
List of Figures
1.2 List of Figures
- Figure 1: Genetic Testing, BRICS, Overall Revenue ($m), 2003-2017
- Figure 2: Genetic Testing, BRICS, Overall Revenue ($m), Historic, 2003-2010
- Figure 3: Genetic Testing, BRICS, Overall Revenue ($m), Forecast, 2010-2017
- Figure 4: Genetic Testing, BRICS, Company share (%), 2010 17
- Figure 5: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, 2003-2017
- Figure 6: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010
- Figure 7: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
- Figure 8: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010
- Figure 9: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017
- Figure 10: Other Genetic Tests, Brazil, Revenue ($m), Historic, 2003-2010
- Figure 11: Other Genetic Tests, Brazil, Revenue ($m), Forecast, 2010-2017
- Figure 12: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010
- Figure 13: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017
- Figure 14: Genetic Testing, Brazil, Company share (%), 2010
- Figure 15: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017
- Figure 16: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010
- Figure 17: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
- Figure 18: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010
- Figure 19: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017
- Figure 20: Other Genetic Tests, Russian Federation, Revenue ($m), Historic, 2003-2010
- Figure 21: Other Genetic Tests, Russian Federation, Revenue ($m), Forecast, 2010-2017
- Figure 22: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010
- Figure 23: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017
- Figure 24: Genetic Testing, Russian Federation, Company share (%), 2010
- Figure 25: Genetic Testing, India, Overall Revenue ($m), USD Actual, 2003-2017 50
- Figure 26: Genetic Testing, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010
- Figure 27: Genetic Testing, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
- Figure 28: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010
- Figure 29: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017
- Figure 30: Other Genetic Tests, India, Revenue ($m), Historic, 2003-2010
- Figure 31: Other Genetic Tests, India, Revenue ($m), Forecast, 2010-2017
- Figure 32: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010
- Figure 33: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017
- Figure 34: Genetic Testing, India, Company share (%), 2010
- Figure 35: Genetic Testing, China, Overall Revenue ($m), USD Actual, 2003-2017
- Figure 36: Genetic Testing, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010
- Figure 37: Genetic Testing, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
- Figure 38: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010
- Figure 39: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017
- Figure 40: Other Genetic Tests, China, Revenue ($m), Historic, 2003-2010
- Figure 41: Other Genetic Tests, China, Revenue ($m), Forecast, 2010-2017
- Figure 42: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010
- Figure 43: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017
- Figure 44: Genetic Testing, China, Company share (%), 2010
- Figure 45: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, 2003-2017
- Figure 46: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010
- Figure 47: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
- Figure 48: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010
- Figure 49: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017
- Figure 50: Other Genetic Tests, South Africa, Revenue ($m), Historic, 2003-2010
- Figure 51: Other Genetic Tests, South Africa, Revenue ($m), Forecast, 2010-2017
- Figure 52: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010
- Figure 53: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017
- Figure 54: Genetic Testing, South Africa, Company share (%), 2010
- Figure 55: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Genetic Testing Market, 2010
- Figure 56: Abbott Laboratories, Company Share (%), BRICS Genetic Testing Market, 2010
- Figure 57: Siemens Healthcare, Company Share (%), BRICS Genetic Testing Market, 2010
- Figure 58: Qiagen N.V., Company Share (%), BRICS Genetic Testing Market, 2010
- Figure 59: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Genetic Testing Market, 2010
- Figure 60: Gen-Probe Incorporated, Company Share (%), BRICS Genetic Testing Market, 2010
|
 |
